Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank van den Hoogen

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 1, 2018
Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar AgentLars Erik Kristensen, Rieke Alten, Luis Puig, et al.
Patient Education and Counseling|August 11, 2012
Development and content of a group-based intervention to improve medication adherence in non-adherent patients with rheumatoid arthritisHanneke Zwikker, Bart van den Bemt, Cornelia van den Ende, et al.
Human Immunology|November 27, 2008
The -2518A>G promoter polymorphism in the CCL2 gene is not associated with systemic sclerosis susceptibility or phenotype: results from a multicenter study of European Caucasian patientsTimothy R D J Radstake, Madelon C Vonk, Marieke Dekkers, et al.
The Journal of Rheumatology|May 16, 2021
Systematic Analysis of the Literature in Search of Defining Systemic Sclerosis SubsetsTatiana Nevskaya, Janet E Pope, Matthew A Turk, et al.
Arthritis Care & Research|November 5, 2011
Validation of potential classification criteria for systemic sclerosisSindhu R Johnson, Jaap Fransen, Dinesh Khanna, et al.
RMD Open|September 17, 2020
What do patients prefer? A multinational, longitudinal, qualitative study on patient-preferred treatment outcomes in early rheumatoid arthritisKristien Van der Elst, Elke G E Mathijssen, Ellen Landgren, et al.
Rheumatology (Oxford, England)|April 22, 2017
Performance of the Patient-Reported Outcomes Measurement Information System-29 in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort StudyLinda Kwakkenbos, Brett D Thombs, Dinesh Khanna, et al.
The American Journal of Medicine|January 11, 2005
Mortality in systemic sclerosis: an international meta-analysis of individual patient dataJohn P A Ioannidis, Panayiotis G Vlachoyiannopoulos, Anna-Bettina Haidich, et al.
RMD Open|July 20, 2020
Considerations for improving quality of care of patients with rheumatoid arthritis and associated comorbiditiesTore K Kvien, Alejandro Balsa, Neil Betteridge, et al.
Arthritis Care & Research|April 25, 2024
Agreement Between Physician Evaluation and the Composite Response Index in Diffuse Cutaneous Systemic SclerosisBoyang Zheng, Mianbo Wang, Kerry McKenna, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 1, 2018
Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar AgentLars Erik Kristensen, Rieke Alten, Luis Puig, et al.
Patient Education and Counseling|August 11, 2012
Development and content of a group-based intervention to improve medication adherence in non-adherent patients with rheumatoid arthritisHanneke Zwikker, Bart van den Bemt, Cornelia van den Ende, et al.
Human Immunology|November 27, 2008
The -2518A>G promoter polymorphism in the CCL2 gene is not associated with systemic sclerosis susceptibility or phenotype: results from a multicenter study of European Caucasian patientsTimothy R D J Radstake, Madelon C Vonk, Marieke Dekkers, et al.
The Journal of Rheumatology|May 16, 2021
Systematic Analysis of the Literature in Search of Defining Systemic Sclerosis SubsetsTatiana Nevskaya, Janet E Pope, Matthew A Turk, et al.
Arthritis Care & Research|November 5, 2011
Validation of potential classification criteria for systemic sclerosisSindhu R Johnson, Jaap Fransen, Dinesh Khanna, et al.
RMD Open|September 17, 2020
What do patients prefer? A multinational, longitudinal, qualitative study on patient-preferred treatment outcomes in early rheumatoid arthritisKristien Van der Elst, Elke G E Mathijssen, Ellen Landgren, et al.
Rheumatology (Oxford, England)|April 22, 2017
Performance of the Patient-Reported Outcomes Measurement Information System-29 in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort StudyLinda Kwakkenbos, Brett D Thombs, Dinesh Khanna, et al.
The American Journal of Medicine|January 11, 2005
Mortality in systemic sclerosis: an international meta-analysis of individual patient dataJohn P A Ioannidis, Panayiotis G Vlachoyiannopoulos, Anna-Bettina Haidich, et al.
RMD Open|July 20, 2020
Considerations for improving quality of care of patients with rheumatoid arthritis and associated comorbiditiesTore K Kvien, Alejandro Balsa, Neil Betteridge, et al.
Arthritis Care & Research|April 25, 2024
Agreement Between Physician Evaluation and the Composite Response Index in Diffuse Cutaneous Systemic SclerosisBoyang Zheng, Mianbo Wang, Kerry McKenna, et al.
Pageof 3